These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21757465)

  • 21. [Pleiotropic effects of statins].
    Mennickent C S; Bravo D M; Calvo M C; Avello L M
    Rev Med Chil; 2008 Jun; 136(6):775-82. PubMed ID: 18769836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins.
    Arnaud C; Burger F; Steffens S; Veillard NR; Nguyen TH; Trono D; Mach F
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1231-6. PubMed ID: 15790934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue-specific effects of atorvastatin on 3-hydroxy-3-methylglutarylcoenzyme A reductase expression and activity in spontaneously hypertensive rats.
    Chen GP; Yao L; Lu X; Li L; Hu SJ
    Acta Pharmacol Sin; 2008 Oct; 29(10):1181-6. PubMed ID: 18817622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of the atorvastatin-clopidogrel drug-drug interaction.
    Lau WC; Carville DG; Bates ER
    Circulation; 2004 Aug; 110(6):e66-7; author reply e66-7. PubMed ID: 15302813
    [No Abstract]   [Full Text] [Related]  

  • 25. Different statins produce highly divergent changes in gene expression profiles of human hepatoma cells: a pilot study.
    Leszczynska A; Gora M; Plochocka D; Hoser G; Szkopinska A; Koblowska M; Iwanicka-Nowicka R; Kotlinski M; Rawa K; Kiliszek M; Burzynska B
    Acta Biochim Pol; 2011; 58(4):635-9. PubMed ID: 22132374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interactions of statins with antithrombotic drugs].
    Ruef J
    Med Klin (Munich); 2004 Feb; 99(2):65-70. PubMed ID: 14963656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of multidrug resistance protein 2 (MRP2, ABCC2) expression by statins: involvement of SREBP-mediated gene regulation.
    Kobayashi M; Gouda K; Chisaki I; Asada K; Ogura J; Takahashi N; Konishi T; Koshida Y; Sasaki S; Yamaguchi H; Iseki K
    Int J Pharm; 2013 Aug; 452(1-2):36-41. PubMed ID: 23612356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atorvastatin restores endothelial function in offspring of protein-restricted rats in a cholesterol-independent manner.
    Torrens C; Kelsall CJ; Hopkins LA; Anthony FW; Curzen NP; Hanson MA
    Hypertension; 2009 Apr; 53(4):661-7. PubMed ID: 19221211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias.
    Lea AP; McTavish D
    Drugs; 1997 May; 53(5):828-47. PubMed ID: 9129869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
    Teupser D; Bruegel M; Stein O; Stein Y; Thiery J
    Biochem Biophys Res Commun; 2001 Dec; 289(4):838-44. PubMed ID: 11735122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation mechanism of ABCA1 expression by statins in hepatocytes.
    Kobayashi M; Gouda K; Chisaki I; Ochiai M; Itagaki S; Iseki K
    Eur J Pharmacol; 2011 Jul; 662(1-3):9-14. PubMed ID: 21554872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stress on pleiotropic effects of statins.
    Mishra PK
    Eur J Cardiothorac Surg; 2006 May; 29(5):861-2; author reply 862. PubMed ID: 16520040
    [No Abstract]   [Full Text] [Related]  

  • 33. Statins amplify TLR-induced responses in microglia via inhibition of cholesterol biosynthesis.
    Van Der Putten C; Kuipers HF; Zuiderwijk-Sick EA; Van Straalen L; Kondova I; Van Den Elsen PJ; Bajramovic JJ
    Glia; 2012 Jan; 60(1):43-52. PubMed ID: 21964955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Re: Efflux transporter-mediated interactions with atorvastatin--interesting findings with multiple substrates: istradefylline, verapamil, and rifampicin.
    Rao N
    J Clin Pharmacol; 2011 May; 51(5):784. PubMed ID: 20671297
    [No Abstract]   [Full Text] [Related]  

  • 35. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins.
    Dansette PM; Jaoen M; Pons C
    Exp Toxicol Pathol; 2000 May; 52(2):145-8. PubMed ID: 10965989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy.
    Rätz Bravo AE; Tchambaz L; Krähenbühl-Melcher A; Hess L; Schlienger RG; Krähenbühl S
    Drug Saf; 2005; 28(3):263-75. PubMed ID: 15733030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atorvastatin: a new agent for hyperlipidemia.
    Kupecz D
    Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876
    [No Abstract]   [Full Text] [Related]  

  • 38. Atorvastatin treatment and vaccination efficacy.
    Packard RR; Schlegel S; Senouf D; Burger F; Sigaud P; Perneger T; Siegrist CA; Mach F
    J Clin Pharmacol; 2007 Aug; 47(8):1022-7. PubMed ID: 17548534
    [No Abstract]   [Full Text] [Related]  

  • 39. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of atorvastatin on lipid metabolism in normolipidemic and hereditary hyperlipidemic, non-laying hens.
    Elkin RG; Zhong Y; Donkin SS; Hengstschläger-Ottnad E; Schneider WJ
    Comp Biochem Physiol B Biochem Mol Biol; 2006 Mar; 143(3):319-29. PubMed ID: 16413806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.